4 November 2025
Clifford Chance advises on Sanofi’s successful SEC-registered USD 3 billion bond issuance across five tranches of floating and fixed rate notes
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Olivier Plessis Lead | Clifford Chance | Not stated | Not stated | London |
| Jill Concannon | Clifford Chance | Not stated | Not stated | London |
| Trey Oxendine | Clifford Chance | Not stated | Not stated | London |
| Tara Kade | Clifford Chance | Not stated | Not stated | London |
| Cédric Burford | Clifford Chance | Not stated | Not stated | Paris |
| Auriane Bijon | Clifford Chance | Not stated | Not stated | Paris |
| Baya Hariche | Clifford Chance | Not stated | Not stated | Paris |
| Avrohom Gelber | Clifford Chance | Not stated | US and French tax matters | New York |
| Gil Shauly | Clifford Chance | Not stated | US and French tax matters | New York |
| Pierre Goyat | Clifford Chance | Not stated | US and French tax matters | Paris |
| Hanene Zemir | Clifford Chance | Not stated | US and French tax matters | Paris |
Stated terms
- Stated value
- USD 3bn (USD 3 billion)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Sanofi (Issuer)
Barclays Capital Inc. (Underwriters)
BNP Paribas Securities Corp. (Underwriters)
BofA Securities, Inc. (Underwriters)
J.P. Morgan Securities LLC (Underwriters)
Morgan Stanley & Co. LLC (Underwriters)
MUFG Securities Americas Inc. (Underwriters)
Natixis Securities Americas LLC (Underwriters)